1. Hewitt RE. Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2011. 23:112–119.
2. Riegman PH, van Veen EB. Biobanking residual tissues. Hum Genet. 2011. 130:357–368.
3. Giannini C, Oelkers MM, Edwards WD, Aubry MC, Muncil MM, Mohamud KH, Sandleback SG, Nowak JM, Bridgeman A, Brown ME, et al. Maintaining clinical tissue archives and supporting human research: challenges and solutions. Arch Pathol Lab Med. 2011. 135:347–353.
4. Ryu YJ, Kim H, Jang S. Proposal for the development of a human biological material management system for research hospitals. J Korean Med Assoc. 2012. 55:292–303.
5. Gefenas E, Dranseika V, Serepkaite J, Cekanauskaite A, Caenazzo L, Gordijn B, Pegoraro R, Yuko E. Turning residual human biological materials into research collections: playing with consent. J Med Ethics. 2012. 38:351–355.
6. Baik SJ, Park O, Kim YJ. Summary of bioethics and safty act: bioethics forum. accessed on 1 March 2013. Available at
http://www.nibp.kr/xe/2117.
7. Bevilacqua G, Bosman F, Dassesse T, Höfler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch. 2010. 456:449–454.
8. Stephenson J. Pathologists enter debate on consent for genetic research on stored tissue. JAMA. 1996. 275:503–504.
10. Bioethics and Safety Act of Korea. No.11250: article 36②: enforcement rule: article 33①. accessed on 1 March 2013. Available at
http://www.law.go.kr/main.html.